Speech-Language Pathologists in Sumrall, MS Accepting Medicare
7 Speech-Language Pathologists found. Showing 1 - 7
 Skylar Michelle Odom Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 668 Old Salt Rd, Sumrall, MS 39482 Phone: 601-270-6968 |
Miss Jessica Renee Parker, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 668 Old Salt Rd, Sumrall, MS 39482 Phone: 601-758-0982 Fax: 601-758-0982 |
Codie Jaclyn Green Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 668 Old Salt Rd, Sumrall, MS 39482 Phone: 601-270-6968 Fax: 601-336-5255 |
Megan Miller Lee Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4881 Hwy 589, Sumrall, MS 39482 Phone: 601-336-9099 Fax: 601-336-9099 |
Lauren Michele Trosclair Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 668 Old Salt Rd, Sumrall, MS 39482 Phone: 601-270-6968 Fax: 601-336-5255 |
Amee Lynne Wayton, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 195 Walker Hill Rd, Sumrall, MS 39482 Phone: 601-307-9720 |
 Aultman Speech Therapy Services, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 668 Old Salt Rd, Sumrall, MS 39482 Phone: 601-270-6968 |
News Archive
Bone density related to duration of lactation
Maternal bone density decreases after childbirth, but only among women who lactate for at least four months. The lactation period is unrelated to vitamin D status. A PhD thesis at Sahlgrenska Academy has explored the issue.
G20 to launch initiative to reduce food price volatility
The G20 plans to launch an initiative aimed at reducing food price volatility when the group's agriculture ministers meet this month in France, the Financial Times reports. According to the newspaper, G20 agriculture ministers will discuss the details of the Agriculture Market Information System (AMIS) initiative during their meeting in Paris, which begins on June 22.
Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa
Santen Pharmaceutical Co., Ltd. and jCyte Inc. announced the conclusion of an exclusive licensing contract covering the development, registration and commercialisation rights in Japan, Asia and Europe to jCell, a first-in-class investigational therapy, currently in clinical development for retinitis pigmentosa.
'Copper' plans? Health law backers push for new, lower premium coverage
Some health law proponents are urging officials to create "copper" plans that offer lower deductibles, but higher out-of-pocket costs than the health law's gold, silver and bronze plans.
Fellowship directors endorse the need for increasing diversity in cardiology
Underrepresented minorities remain few in number among practicing cardiologists and across cardiology fellowship training programs in the United States, with fellowship directors agreeing that increased diversity is needed in the field and is particularly necessary within graduate medical education cardiology fellowship training programs.
› Verified 5 days ago